J84.10
Pulmonary fibrosis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Capillary fibrosis of lung
- Cirrhosis of lung (chronic) NOS
- Fibrosis of lung (atrophic) (chronic) (confluent) (massive) (perialveolar) (peribronchial) NOS
- Induration of lung (chronic) NOS
- Postinflammatory pulmonary fibrosis
Medical Intelligence & Overview
Pulmonary fibrosis is a lung condition characterized by the thickening and scarring of lung tissue, which can impair breathing and oxygen transfer. When classified as unspecified (ICD-10 Code J84.10), it indicates that the precise cause or pattern of fibrosis has not been determined. This condition affects the tissue's ability to expand and contract normally, leading to a gradual decline in lung function over time.
Causes & Symptoms
Clinical Causes: Chronic inflammatory processes in the lungs following infections or exposure to harmful substances Long-term exposure to environmental or occupational irritants such as asbestos, coal dust, or silica dust Certain medications or treatments, including radiation therapy Autoimmune diseases like scleroderma or rheumatoid arthritis that affect lung tissue Genetic predispositions that may lead to abnormal tissue repair Idiopathic origins, where no specific cause is identified
Key Symptoms: Shortness of breath, especially during physical activity Persistent dry cough Fatigue and weakness Unexplained weight loss Chest discomfort or pain Clubbing of fingers (enlargement of fingertips)
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and various tests: - Chest X-rays to identify abnormalities - High-resolution computed tomography (HRCT) scans for detailed lung imaging - Pulmonary function tests (PFTs) to assess lung capacity and airflow - Blood tests to rule out other conditions - Sometimes, a lung biopsy may be performed to examine lung tissue more closely Understanding the pattern and extent of fibrosis helps guide appropriate management strategies.
Treatment Protocols: While there is no cure for pulmonary fibrosis, treatments aim to manage symptoms and slow disease progression: - Use of antifibrotic medications to reduce scarring - Oxygen therapy to support breathing - Pulmonary rehabilitation programs to improve lung efficiency and overall fitness - Vaccinations to prevent respiratory infections - In severe cases, lung transplantation may be considered Supportive care and regular monitoring are essential for maintaining quality of life.
Clinical Advice & FAQs
Billing Guidance
Is J84.10 a billable ICD-10 code?
Yes, J84.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.10?
Clinical documentation must specify the nature of Pulmonary fibrosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference